title: Editorial Commentary: Neurocognitive Performance in Ritonavir-boosted Protease Inhibitor Monotherapy.
authors.affiliation: Department of Psychiatry, University of Toronto St. Michael's Hospital Centre for Research on Inner City Health, The Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
authors.forename: Adriana
authors.initials: A
authors.lastname: Carvalhal
mesh_terms: D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D061466:Lopinavir / Q000627:therapeutic use; D019438:Ritonavir / Q000494:pharmacology*
chemical_list: D017320:HIV Protease Inhibitors; D061466:Lopinavir; D019438:Ritonavir
keywords: monotherapy; neurocognitive performance; protease inhibitor